Transaction in Own Shares

Summary by AI BETAClose X

Ryanair Holdings plc has announced that between January 19 and January 23, 2026, it purchased for cancellation a total of 8,218 ordinary shares at an average price of approximately €28.85 and 345,408 ordinary shares underlying American Depositary Shares, with prices ranging from US $34.61 to US $35.69. These transactions are part of the company's ongoing share buy-back program initiated on May 20, 2025, and all repurchased shares will be cancelled.

Disclaimer*

Ryanair Holdings PLC
26 January 2026
 

Ryanair Holdings plc

Transactions in own shares

Ryanair Holdings plc (the "Company") announces that in the period 19 January 2026 to 23 January 2026 it purchased for cancellation in aggregate 8,218 ordinary shares of nominal value €0.006 each in the capital of the Company ("Ordinary Shares") and in aggregate 345,408 Ordinary Shares underlying the American Depositary Shares, as further detailed below.

Date

Number of Ordinary Shares

Volume weighted average price paid

Number of Ordinary Shares underlying American Depositary Shares

Volume weighted average price paid

19 January 2026

1,912

€28.788

-

-

20 January 2026

1,262

€28.570

86,542

US $34.6135

21 January 2026

1,362

€29.056

86,312

US $35.2214

22 January 2026

1,812

€29.494

86,548

US $35.6883

23 January 2026

1,870

€28.618

86,006

US $35.0269

 

These share purchases form part of the Company's existing share buy-back programme, details of which were announced on 20 May 2025 (the "Programme").  Purchases made under the share buyback programme will be announced on a weekly basis.

 

All shares purchased by the Company will be cancelled. This announcement is being made in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended. 

Issuer name:


Ryanair Holdings plc


LEI


635400BR2ROC1FVEBQ56

ISIN:


IE00BYTBXV33

 

Enquiries:

Contact:

Jamie Donovan

Ryanair Holdings Plc

Tel: + 353 1 945 1212

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings